CAR‐NK cells: the next wave of cellular therapy for cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CAR‐NK cells: the next wave of cellular therapy for cancer

Published:2021-01 Issue:4 Volume:10 Page:
ISSN:2050-0068
Container-title:Clinical & Translational Immunology
language:en
Short-container-title:Clin Transl Immunol

Author:

Daher May¹,Melo Garcia Luciana¹,Li Ye¹,Rezvani Katayoun¹

Affiliation:

1. Department of Stem Cell Transplantation and Cellular Therapy The University of Texas MD Anderson Cancer Center Houston TX USA

Funder

Stand Up To Cancer

Cancer Prevention and Research Institute of Texas

National Cancer Institute

Publisher

Wiley

Subject

General Nursing,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cti2.1274

Reference92 articles.

1. T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia

2. The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice

3. Chimeric Antigen Receptor Therapy for Cancer

4. Chimeric Antigen Receptor Therapy

5. Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photoporation of NK-92MI cells with biodegradable polydopamine nanosensitizers as a promising strategy for the generation of engineered NK cell therapies;Applied Materials Today;2024-10

2. Enhancing natural killer cells proliferation and cytotoxicity using imidazole-based lipid nanoparticles encapsulating interleukin-2 mRNA;Molecular Therapy - Nucleic Acids;2024-09

3. Advances in CAR-NK cell therapy for hematological malignancies;Frontiers in Immunology;2024-06-28

4. The impact of, and expectations for, lipid nanoparticle technology: From cellular targeting to organelle targeting;Journal of Controlled Release;2024-06

5. Chimeric antigen receptor T-cell therapy in childhood acute myeloid leukemia: how far are we from a clinical application?;Haematologica;2024-05-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3